Achieve Life Sciences, Inc. (ACHV) — Financial statements
Income statement, balance sheet, and cash flow for Achieve Life Sciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.23↓0.4% | 0.23 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.23↑0.4% | -0.23 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 23↑0.6% | 23↑44.3% | 16↓47.4% | 30↑25.5% | 24 | |
| General & Administrative Expenses | 32↑96.1% | 16↑42.1% | 11↑6.7% | 11↑17.5% | 9 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 32↑96.1% | 16↑42.1% | 11↑6.7% | 11↑17.5% | 9 | |
| Other Expenses | 0.05↑121.0% | -0.23 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 55↑40.7% | 39↑42.5% | 27↓33.2% | 41↑23.3% | 33 | |
| Total Costs & Expenses | 55↑40.5% | 39↑43.4% | 27↓33.2% | 41↑23.3% | 33 | |
| Operating Results | ||||||
| Operating Income | -55↓40.5% | -39↓43.4% | -27↑33.2% | -41↓23.3% | -33 | |
| Depreciation & Amortization | 0.23↓0.4% | 0.23↑0.4% | 0.23↓3.4% | 0.24↓5.6% | 0.25 | |
| EBITDA | -55↓46.1% | -37↓40.0% | -27↑33.7% | -40↓22.6% | -33 | |
| EBIT | -55↓45.8% | -38↓39.6% | -27↑33.5% | -41↓22.3% | -33 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.68↑284.1% | 0.18↑108.7% | -2↓27.5% | -2↓9452.9% | 0.02 | |
| Interest Income | 1↓36.5% | 2↑185.6% | 0.83↑314.6% | 0.20↑1070.6% | 0.02 | |
| Interest Expense | 0.82↓62.4% | 2↓23.6% | 3↑59.5% | 2 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -1↓393.8% | -0.29↓20.5% | -0.24↓512.1% | 0.06 | |
| Other Income / Expenses | 0.23↑130.6% | -0.76↑70.4% | -3↓65.5% | -2↓2572.4% | -0.06 | |
| Income Before Tax | -55↓37.2% | -40↓33.6% | -30↑29.6% | -42↓27.7% | -33 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -55↓37.2% | -40↓33.6% | -30↑29.6% | -42↓27.7% | -33 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -55↓37.2% | -40↓33.6% | -30↑29.6% | -42↓27.7% | -33 | |
| Bottom-Line Net Income | -55↓37.2% | -40↓33.6% | -30↑29.6% | -42↓27.7% | -33 | |
| EPS (Basic) | -1.25↓0.8% | -1.24↑17.3% | -1.50↑62.0% | -3.95↑2.5% | -4.05 | |
| EPS (Diluted) | -1.25↓0.8% | -1.24↑17.3% | -1.50↑62.0% | -3.95↑2.5% | -4.05 | |
| Weighted Average Shares | 44↑35.9% | 32↑61.8% | 20↑87.2% | 11↑30.5% | 8 | |
| Weighted Average Diluted Shares | 44↑35.9% | 32↑61.8% | 20↑87.2% | 11↑30.5% | 8 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.